Lumo Homes prices EUR 300 million senior unsecured bond under EMTN programme
Lumos Pharma
Lumos Pharma LUMO | 0.00 |
- Lumo Kodit priced EUR 300 million senior unsecured notes under its EMTN programme.
- Notes mature May 20, 2030, carrying 4% fixed annual coupon; expected Moody’s rating Baa2.
- Proceeds earmarked to partly refinance EUR 600 million acquisition financing tied to purchase of 4,761 apartments from Varma.
- Admission to trading targeted on regulated market of Euronext Dublin.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lumo Kodit Oyj published the original content used to generate this news brief via Cision (Ref. ID: 20260512:BIT:1941:0) on May 12, 2026, and is solely responsible for the information contained therein.
